Massimo Crapis
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 6
- COVID-19 Clinical Research Studies 6
- Epidemiology 15
- Infective Endocarditis Diagnosis and Management 8
- Sepsis Diagnosis and Treatment 2
- Respiratory viral infections research 2
- Co-authors
- Pierluigi Viale (9 shared papers)Federico Pea (9 shared papers)Matteo Bassetti (8 shared papers)Camilla Negri (3 shared papers)Francesco Cristini (3 shared papers)Pier Giorgio Cojutti (7 shared papers)Mario Furlanut (2 shared papers)Assunta Sartor (5 shared papers)
- Journals
- International Journal of Antimicrobial Agents (6 papers)Infection (3 papers)Future Microbiology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)International Journal of Cardiology (2 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Massimo Crapis
45 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 58
- Molecular Medicine 276
- Applied Microbiology and Biotechnology 44
- Pharmacology 225
- Infectious Diseases 198
- Epidemiology 290
Countries citing papers authored by Massimo Crapis
This map shows the geographic impact of Massimo Crapis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Crapis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Crapis more than expected).
Fields of papers citing papers by Massimo Crapis
This network shows the impact of papers produced by Massimo Crapis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Crapis. The network helps show where Massimo Crapis may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Crapis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 144 | |
| 2 | 2012 | 130 | |
| 3 | 2020 | 113 | |
| 4 | 2009 | 101 | |
| 5 | 2014 | 81 | |
| 6 | 2016 | 63 | |
| 7 | 2020 | 60 | |
| 8 | 2016 | 41 | |
| 9 | 2017 | 41 | |
| 10 | 2008 | 38 | |
| 11 | 2020 | 35 | |
| 12 | 2008 | 30 | |
| 13 | 2006 | 23 | |
| 14 | 2020 | 22 | |
| 15 | 2013 | 15 | |
| 16 | 2014 | 15 | |
| 17 | 2022 | 15 | |
| 18 | 2008 | 13 | |
| 19 | 2014 | 13 | |
| 20 | 2021 | 13 |
About Massimo Crapis
Massimo Crapis is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Infective Endocarditis Diagnosis and Management (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers), COVID-19 Clinical Research Studies (6 papers), Antibiotic Resistance in Bacteria (4 papers), Antibiotic Use and Resistance (4 papers), Sepsis Diagnosis and Treatment (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Molecular Medicine (276 citations), Applied Microbiology and Biotechnology (44 citations), Pharmacology (225 citations), Infectious Diseases (198 citations) and Epidemiology (290 citations). Massimo Crapis has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Pierluigi Viale, Federico Pea, Matteo Bassetti, Camilla Negri, Francesco Cristini, Pier Giorgio Cojutti, Mario Furlanut, Assunta Sartor, Emanuele Durante‐Mangoni and Claudio Scarparo. Their work appears in journals such as International Journal of Antimicrobial Agents, Infection, Future Microbiology, Antimicrobial Agents and Chemotherapy and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.